Updated overview on the interplay between obesity and COVID-19
Abstract The worldwide spread of coronavirus disease 2019 (COVID-19) has generated a global health crisis and more than a million deaths so far. Epidemiological and clinical characteristics of COVID-19 are increasingly reported, along with its potential relationship with overweight and/or obesity. Therefore, we aim here to review the current scientific literature on the impact of overweight and/or obesity among hospitalized patients who have developed severe or critical forms of COVID-19. Following PRISMA guidelines, our literature search identified over 300 scientific articles using the keywords “obesity” and “COVID-19”, 22 of which were finally selected for reporting useful information on the association between overweight/obesity and disease severity. In particular, in 11 out of the 14 studies (79%) which evaluated the association between obesity and disease severity providing also a risk estimate (i.e., the odd ratio; OR), the OR value was constantly >2. Although the studies were found to be heterogeneous in terms of design, population, sample size and endpoints, in most cases a significant association was found between obesity and the risk of progressing to severe COVID-19 illness, intensive care unit admission and/or death. We can hence conclude that an increased body mass index shall be considered a negative prognostic factor in patients with COVID-19, and more aggressive prevention or treatment shall hence be reserved to overweight and/or obese patients..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
---|---|
Enthalten in: |
Diagnosis - 8(2020), 1 vom: 19. Nov., Seite 5-16 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Onorato, Diletta [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Anmerkungen: |
© 2020 Walter de Gruyter GmbH, Berlin/Boston |
---|
doi: |
10.1515/dx-2020-0111 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC2142426670 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC2142426670 | ||
003 | DE-627 | ||
005 | 20231205151734.0 | ||
007 | tu | ||
008 | 230813s2020 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1515/dx-2020-0111 |2 doi | |
035 | |a (DE-627)OLC2142426670 | ||
035 | |a (DE-B1597)dx-2020-0111-p | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
082 | 0 | 4 | |a 610 |q VZ |
100 | 1 | |a Onorato, Diletta |e verfasserin |0 (orcid)0000-0002-6147-7115 |4 aut | |
245 | 1 | 0 | |a Updated overview on the interplay between obesity and COVID-19 |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a © 2020 Walter de Gruyter GmbH, Berlin/Boston | ||
520 | |a Abstract The worldwide spread of coronavirus disease 2019 (COVID-19) has generated a global health crisis and more than a million deaths so far. Epidemiological and clinical characteristics of COVID-19 are increasingly reported, along with its potential relationship with overweight and/or obesity. Therefore, we aim here to review the current scientific literature on the impact of overweight and/or obesity among hospitalized patients who have developed severe or critical forms of COVID-19. Following PRISMA guidelines, our literature search identified over 300 scientific articles using the keywords “obesity” and “COVID-19”, 22 of which were finally selected for reporting useful information on the association between overweight/obesity and disease severity. In particular, in 11 out of the 14 studies (79%) which evaluated the association between obesity and disease severity providing also a risk estimate (i.e., the odd ratio; OR), the OR value was constantly >2. Although the studies were found to be heterogeneous in terms of design, population, sample size and endpoints, in most cases a significant association was found between obesity and the risk of progressing to severe COVID-19 illness, intensive care unit admission and/or death. We can hence conclude that an increased body mass index shall be considered a negative prognostic factor in patients with COVID-19, and more aggressive prevention or treatment shall hence be reserved to overweight and/or obese patients. | ||
700 | 1 | |a Carpenè, Giovanni |4 aut | |
700 | 1 | |a Lippi, Giuseppe |0 (orcid)0000-0001-9523-9054 |4 aut | |
700 | 1 | |a Pucci, Mairi |0 (orcid)0000-0001-7550-4893 |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diagnosis |d De Gruyter, 2014 |g 8(2020), 1 vom: 19. Nov., Seite 5-16 |w (DE-627)784986606 |w (DE-600)2767943-3 |w (DE-576)405201451 |x 2194-8011 |7 nnns |
773 | 1 | 8 | |g volume:8 |g year:2020 |g number:1 |g day:19 |g month:11 |g pages:5-16 |
856 | 4 | 1 | |u https://doi.org/10.1515/dx-2020-0111 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a GBV_ILN_267 | ||
912 | |a GBV_ILN_4277 | ||
951 | |a AR | ||
952 | |d 8 |j 2020 |e 1 |b 19 |c 11 |h 5-16 |